Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Non-Current Debt (2018 - 2025)

Rockwell Medical (RMTI) has disclosed Non-Current Debt for 10 consecutive years, with $8.7 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Non-Current Debt rose 4.22% year-over-year to $8.7 million, compared with a TTM value of $8.7 million through Sep 2025, up 4.22%, and an annual FY2024 reading of $8.5 million, up 2.16% over the prior year.
  • Non-Current Debt was $8.7 million for Q3 2025 at Rockwell Medical, up from $8.6 million in the prior quarter.
  • Across five years, Non-Current Debt topped out at $21.0 million in Q1 2021 and bottomed at $3.3 million in Q3 2023.
  • Average Non-Current Debt over 5 years is $9.4 million, with a median of $8.5 million recorded in 2024.
  • The sharpest move saw Non-Current Debt crashed 62.83% in 2023, then skyrocketed 151.67% in 2024.
  • Year by year, Non-Current Debt stood at $13.2 million in 2021, then tumbled by 42.7% to $7.6 million in 2022, then increased by 9.77% to $8.3 million in 2023, then rose by 2.16% to $8.5 million in 2024, then grew by 3.13% to $8.7 million in 2025.
  • Business Quant data shows Non-Current Debt for RMTI at $8.7 million in Q3 2025, $8.6 million in Q2 2025, and $8.6 million in Q1 2025.